KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Equity Income (2017 - 2025)

Astrana Health's Equity Income history spans 9 years, with the latest figure at $1.0 million for Q3 2025.

  • For Q3 2025, Equity Income fell 24.69% year-over-year to $1.0 million; the TTM value through Sep 2025 reached $2.1 million, down 60.89%, while the annual FY2024 figure was $4.5 million, 20.22% down from the prior year.
  • Equity Income for Q3 2025 was $1.0 million at Astrana Health, up from $381000.0 in the prior quarter.
  • Across five years, Equity Income topped out at $2.7 million in Q2 2023 and bottomed at -$6.5 million in Q4 2021.
  • The 5-year median for Equity Income is $1.0 million (2025), against an average of $316105.3.
  • The largest annual shift saw Equity Income plummeted 475.78% in 2021 before it surged 1000.0% in 2022.
  • A 5-year view of Equity Income shows it stood at -$6.5 million in 2021, then skyrocketed by 118.85% to $1.2 million in 2022, then soared by 102.04% to $2.5 million in 2023, then tumbled by 36.81% to $1.6 million in 2024, then tumbled by 34.85% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Equity Income are $1.0 million (Q3 2025), $381000.0 (Q2 2025), and -$867000.0 (Q1 2025).